Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
The Cumulative Value Days Destroyed (CVDD) metric has historically called Bitcoin price cycle lows almost to perfection across every cycle since Bitcoin’s inception. This metric begins with Coin Days ...
Novartis (SWX:NOVN) is back on many investors radar after two clear clinical wins: a broader US FDA approval for Itvisma in spinal muscular atrophy and strong Phase III data for ianalumab in immune ...
Dave & Buster's (PLAY) reported $448.2 million in revenue for the quarter ended October 2025, representing a year-over-year decline of 1.1%. EPS of -$1.14 for the same period compares to -$0.45 a year ...
OpenAI's (OPENAI) ChatGPT launched three years ago and its parent has since grown into a startup worth half a trillion dollars. Here's a look at some major events since ChatGPT first greeted users ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Prediction market Kalshi has closed a $1 billion funding round at a valuation of $11 billion, after seeing its best-ever monthly volume in November. Confirming an earlier report by TechCrunch, Kalshi ...
Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...
Analysts maintain a broadly bullish stance on cybersecurity giant CrowdStrike Holdings Inc. (NASDAQ: CRWD) ahead of the company’s third-quarter results on Tuesday. On Monday, Keybanc analysts raised ...
Artificial intelligence (AI) was a key driver of global deals in 2025, with Time Magazine naming “The Architects of AI” as its person of the year. Meanwhile, South Africa saw two stock exchange ...
Other includes workforce reorganization and expense related to litigation. The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties ...